Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Thymus Gland | 4 | 2017 | 126 | 1.15 | Why? |
| Lymphatic Diseases | 1 | 2017 | 96 | 0.63 | Why? |
| Radiation Exposure | 2 | 2018 | 161 | 0.61 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.58 | Why? |
| High-Throughput Screening Assays | 1 | 2018 | 1783 | 0.38 | Why? |
| Adjuvants, Immunologic | 4 | 2021 | 1709 | 0.37 | Why? |
| Radiation, Ionizing | 2 | 2018 | 39 | 0.36 | Why? |
| Lymphopoiesis | 1 | 2006 | 26 | 0.33 | Why? |
| Viral Vaccines | 4 | 2021 | 7560 | 0.32 | Why? |
| Drug Evaluation, Preclinical | 1 | 2018 | 3347 | 0.31 | Why? |
| Aging | 4 | 2018 | 3581 | 0.30 | Why? |
| Leptin | 1 | 2006 | 141 | 0.28 | Why? |
| Antigens, CD7 | 1 | 2004 | 2 | 0.28 | Why? |
| Lipopolysaccharides | 2 | 2006 | 848 | 0.27 | Why? |
| CD28 Antigens | 1 | 2004 | 39 | 0.27 | Why? |
| Receptors, Interleukin-2 | 1 | 2004 | 115 | 0.26 | Why? |
| Cell Division | 2 | 2018 | 136 | 0.25 | Why? |
| Thyroiditis | 1 | 2004 | 104 | 0.24 | Why? |
| Drug Carriers | 2 | 2018 | 590 | 0.23 | Why? |
| Nucleotides, Cyclic | 2 | 2018 | 32 | 0.23 | Why? |
| Dendritic Cells | 3 | 2018 | 1330 | 0.21 | Why? |
| Antibodies, Neutralizing | 8 | 2021 | 25288 | 0.21 | Why? |
| Toll-Like Receptor 2 | 2 | 2018 | 198 | 0.20 | Why? |
| Homeostasis | 1 | 2004 | 582 | 0.20 | Why? |
| Radiation Injuries, Experimental | 1 | 2017 | 5 | 0.18 | Why? |
| Simian Immunodeficiency Virus | 1 | 2021 | 251 | 0.18 | Why? |
| Acute Radiation Syndrome | 1 | 2017 | 5 | 0.18 | Why? |
| Diglycerides | 1 | 2017 | 32 | 0.18 | Why? |
| Radiation-Protective Agents | 1 | 2017 | 9 | 0.18 | Why? |
| Nuclear Weapons | 1 | 2018 | 12 | 0.18 | Why? |
| Lymphoid Progenitor Cells | 1 | 2017 | 3 | 0.18 | Why? |
| Porins | 1 | 2018 | 45 | 0.18 | Why? |
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2018 | 108 | 0.18 | Why? |
| Toll-Like Receptor 6 | 1 | 2017 | 44 | 0.18 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2021 | 556 | 0.18 | Why? |
| B-Lymphocytes | 4 | 2021 | 4418 | 0.17 | Why? |
| Gamma Rays | 1 | 2017 | 108 | 0.17 | Why? |
| Germinal Center | 1 | 2020 | 332 | 0.17 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2020 | 4545 | 0.17 | Why? |
| env Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 386 | 0.17 | Why? |
| Hematopoiesis | 1 | 2017 | 168 | 0.16 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.16 | Why? |
| Protein Folding | 1 | 2018 | 270 | 0.16 | Why? |
| Neisseria gonorrhoeae | 1 | 2018 | 142 | 0.16 | Why? |
| Bone Marrow Cells | 1 | 2017 | 186 | 0.16 | Why? |
| Drug Compounding | 1 | 2018 | 386 | 0.16 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.15 | Why? |
| T-Lymphocyte Subsets | 1 | 2004 | 1387 | 0.15 | Why? |
| Mice, Inbred C57BL | 6 | 2018 | 5542 | 0.15 | Why? |
| AIDS Vaccines | 1 | 2020 | 452 | 0.15 | Why? |
| Dual Specificity Phosphatase 3 | 1 | 2014 | 2 | 0.15 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.14 | Why? |
| Survivors | 2 | 2018 | 2619 | 0.14 | Why? |
| RNA, Messenger | 2 | 2020 | 5131 | 0.14 | Why? |
| Gonorrhea | 1 | 2018 | 315 | 0.13 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.13 | Why? |
| Polysaccharides | 1 | 2021 | 854 | 0.13 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.13 | Why? |
| Mice | 10 | 2021 | 21357 | 0.13 | Why? |
| Intersectoral Collaboration | 1 | 2020 | 1065 | 0.12 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2014 | 249 | 0.12 | Why? |
| Cells, Cultured | 6 | 2020 | 5835 | 0.12 | Why? |
| Radiation Dosage | 1 | 2017 | 585 | 0.12 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.11 | Why? |
| Autoantigens | 1 | 2014 | 388 | 0.11 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.11 | Why? |
| Vaccines, Synthetic | 2 | 2020 | 3231 | 0.11 | Why? |
| Mice, Inbred BALB C | 4 | 2021 | 5814 | 0.11 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.10 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.10 | Why? |
| Animals | 13 | 2021 | 78931 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Gene Expression Profiling | 1 | 2021 | 3788 | 0.10 | Why? |
| Dextrans | 2 | 2018 | 35 | 0.09 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.09 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.09 | Why? |
| Antibodies, Monoclonal | 3 | 2021 | 8041 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Mice, Obese | 1 | 2006 | 29 | 0.08 | Why? |
| Corticosterone | 1 | 2006 | 18 | 0.08 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Injections, Intraperitoneal | 1 | 2006 | 69 | 0.08 | Why? |
| Japan | 2 | 2018 | 6653 | 0.08 | Why? |
| HIV-1 | 1 | 2021 | 3365 | 0.08 | Why? |
| Atrophy | 1 | 2006 | 192 | 0.08 | Why? |
| Mice, Knockout | 2 | 2017 | 1815 | 0.08 | Why? |
| Lymphocyte Activation | 3 | 2020 | 2742 | 0.07 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.07 | Why? |
| Concanavalin A | 1 | 2004 | 19 | 0.07 | Why? |
| B7-1 Antigen | 1 | 2004 | 39 | 0.07 | Why? |
| Staphylococcal Infections | 1 | 2014 | 1099 | 0.07 | Why? |
| B7-2 Antigen | 1 | 2004 | 56 | 0.07 | Why? |
| Zika Virus | 1 | 2017 | 1924 | 0.07 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.06 | Why? |
| Nanoparticles | 3 | 2021 | 2040 | 0.06 | Why? |
| Antigen-Presenting Cells | 1 | 2004 | 206 | 0.06 | Why? |
| Bacteremia | 1 | 2014 | 1372 | 0.06 | Why? |
| Zika Virus Infection | 1 | 2017 | 1920 | 0.06 | Why? |
| CD3 Complex | 1 | 2004 | 237 | 0.06 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2018 | 2941 | 0.06 | Why? |
| Species Specificity | 1 | 2006 | 1356 | 0.06 | Why? |
| Protein Denaturation | 1 | 2021 | 78 | 0.06 | Why? |
| Gene Expression Regulation | 1 | 2014 | 4020 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Disease Susceptibility | 1 | 2014 | 4002 | 0.05 | Why? |
| Polysorbates | 1 | 2020 | 125 | 0.05 | Why? |
| Haplorhini | 1 | 2021 | 307 | 0.05 | Why? |
| Squalene | 1 | 2020 | 196 | 0.05 | Why? |
| T-Lymphocytes | 1 | 2017 | 6670 | 0.05 | Why? |
| Dimerization | 1 | 2021 | 475 | 0.05 | Why? |
| RNA, Guide | 1 | 2021 | 269 | 0.05 | Why? |
| Macaca | 1 | 2021 | 388 | 0.05 | Why? |
| Spleen | 1 | 2004 | 877 | 0.05 | Why? |
| Cold Temperature | 1 | 2021 | 260 | 0.05 | Why? |
| Acetylation | 1 | 2018 | 124 | 0.05 | Why? |
| Macaca mulatta | 2 | 2021 | 3716 | 0.05 | Why? |
| Immunophenotyping | 1 | 2004 | 1290 | 0.05 | Why? |
| Receptors, Antigen, B-Cell | 1 | 2021 | 424 | 0.05 | Why? |
| Surface Plasmon Resonance | 1 | 2021 | 440 | 0.05 | Why? |
| Hemagglutination Inhibition Tests | 1 | 2018 | 191 | 0.05 | Why? |
| Interferometry | 1 | 2018 | 74 | 0.05 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.05 | Why? |
| Antigens, CD | 1 | 2004 | 984 | 0.04 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.04 | Why? |
| Toll-Like Receptor 8 | 1 | 2018 | 102 | 0.04 | Why? |
| Whole-Body Irradiation | 1 | 2017 | 42 | 0.04 | Why? |
| Ovalbumin | 1 | 2017 | 84 | 0.04 | Why? |
| Proto-Oncogene Proteins c-kit | 1 | 2017 | 59 | 0.04 | Why? |
| Dose-Response Relationship, Radiation | 1 | 2018 | 133 | 0.04 | Why? |
| Protein Stability | 1 | 2021 | 756 | 0.04 | Why? |
| Receptors, Pattern Recognition | 1 | 2018 | 128 | 0.04 | Why? |
| RNA, Viral | 3 | 2020 | 32276 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Down-Regulation | 1 | 2004 | 1416 | 0.04 | Why? |
| Receptors, IgG | 1 | 2021 | 578 | 0.04 | Why? |
| Recombinant Proteins | 2 | 2020 | 3786 | 0.04 | Why? |
| Injections, Intradermal | 1 | 2017 | 102 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2018 | 501 | 0.04 | Why? |
| Hemagglutinins, Viral | 1 | 2018 | 176 | 0.04 | Why? |
| Glycosylation | 1 | 2021 | 1255 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Cell Lineage | 1 | 2017 | 241 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.04 | Why? |
| RNA Stability | 1 | 2017 | 285 | 0.04 | Why? |
| CD8-Positive T-Lymphocytes | 2 | 2020 | 5837 | 0.04 | Why? |
| Cell Line, Transformed | 1 | 2014 | 87 | 0.04 | Why? |
| HIV Antibodies | 1 | 2021 | 776 | 0.04 | Why? |
| Immunity, Cellular | 2 | 2018 | 3614 | 0.04 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.04 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.04 | Why? |
| Toll-Like Receptor 7 | 1 | 2018 | 402 | 0.04 | Why? |
| Inflammation Mediators | 1 | 2006 | 2654 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2004 | 2273 | 0.03 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.03 | Why? |
| Immunity, Humoral | 2 | 2020 | 4849 | 0.03 | Why? |
| Animals, Genetically Modified | 1 | 2014 | 230 | 0.03 | Why? |
| Immunogenicity, Vaccine | 2 | 2020 | 4624 | 0.03 | Why? |
| Leukocyte Count | 1 | 2004 | 3178 | 0.03 | Why? |
| Pneumonia, Bacterial | 1 | 2021 | 843 | 0.03 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.03 | Why? |
| Acute Disease | 1 | 2006 | 6029 | 0.03 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.03 | Why? |
| Cryoelectron Microscopy | 1 | 2021 | 2372 | 0.03 | Why? |
| Imidazoles | 1 | 2018 | 631 | 0.03 | Why? |
| Furin | 1 | 2020 | 1054 | 0.03 | Why? |
| Signal Transduction | 2 | 2021 | 7207 | 0.03 | Why? |
| Male | 11 | 2021 | 367725 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Vaccines, Subunit | 1 | 2018 | 1088 | 0.03 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Betacoronavirus | 3 | 2021 | 204454 | 0.03 | Why? |
| Glycoproteins | 1 | 2017 | 615 | 0.03 | Why? |
| Lymphocyte Count | 1 | 2004 | 4758 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Lymphopenia | 1 | 2004 | 2669 | 0.03 | Why? |
| Antigens, Viral | 2 | 2020 | 6298 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| RNA Interference | 1 | 2014 | 534 | 0.03 | Why? |
| Immunization | 1 | 2020 | 2019 | 0.03 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.02 | Why? |
| Genome-Wide Association Study | 1 | 2014 | 1648 | 0.02 | Why? |
| Models, Molecular | 1 | 2021 | 7616 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Influenza, Human | 2 | 2021 | 10779 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 2984 | 0.02 | Why? |
| Macrophages | 1 | 2014 | 2784 | 0.01 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2018 | 88759 | 0.01 | Why? |
| Immunity, Innate | 1 | 2014 | 6570 | 0.01 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Aged | 2 | 2018 | 215776 | 0.01 | Why? |
| Adult | 1 | 2018 | 244371 | 0.00 | Why? |
Sempowski's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(211)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(208)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_